Urothelial Carcinoma Detection Kits-TBG Biotechnology Corp.

TBG Biotechnology

Media Partnering

Language

简体中文

Reagents

COVID 19 Testing Kits HLA SSP Typing Kits HLA SBT Typing Kits

HPA Genotyping Kits Reagents and Accessories Reagent Analysis Software

HLA Real Time PCR Typing Kits Nucleic Acid Extraction Kits Urothelial Carcinoma Detection Tests

HLA NGS Typing Kits Analysis Software
Equipments

Nucleic Acid Extraction Systems Automated Pipetting System Real Time PCR System
Service

HLA Genotyping Manufacturing
Research & Development

Benefits of Molecular Diagnostics Sequence Specific Primers Sequencing Based Typing

Links to Resources Developing Products
About TBG

Company Introduction Our Vision Our Board of Directors

Career Opportunities Quality systems

Contact us
Investor Center

Financial Reports Research

Presentations Company Announcements Corporate Governance

Home / REAGENTS / Detail

Urothelial Carcinoma Detection Tests

Urothelial Carcinoma Detection Kits

Intended Use

This kit detects the presence of Urothelial Carcinoma with by a DNA-based method.

Feature and Benefits

Detects the presence of methlation on NRN1 and mutations on TERT1 and FGFR3.
Turn Around Time for the entire process is about 3 hours

Specifications

Includes Urine Collection Kit. This contains an Urine Collection Tube and a Urine Collection Cup.
Includes Sample Extraction Kit.
Includes PCR Detection Kit

Workflow

Step 1 Urine Collection

Step 2 Sample Extraction

Step 3. Real Time PCR Reaction

Step 4 Data Analysis.

Ordering Information

Please contact your nearest TBG contact for more details.

Regulations

RUO / IUO